NCT03312361View on ClinicalTrials.gov

Assessing Air Travel Safety in Neuromuscular Dystrophy: Standard Versus Prolonged High Altitude Simulation Tests

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

April 1, 2018

Study Completion Date

April 1, 2018

Conditions
Neuromuscular DiseasesHigh Altitude Hypoxia
Interventions
DRUG

15% oxygen

Participants will inhale 15% oxygen for 2 hours to see how it affects them.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT03312361 - Assessing Air Travel Safety in Neuromuscular Dystrophy: Standard Versus Prolonged High Altitude Simulation Tests | Biotech Hunter | Biotech Hunter